中华核医学与分子影像杂志
中華覈醫學與分子影像雜誌
중화핵의학여분자영상잡지
Chinese Journal of Nuclear Medicine and Molecular Imaging
2015年
2期
102-107
,共6页
于雷%王莹莹%胡祥华%孙洪飞%车现锋%陈继锁%孙效刚
于雷%王瑩瑩%鬍祥華%孫洪飛%車現鋒%陳繼鎖%孫效剛
우뢰%왕형형%호상화%손홍비%차현봉%진계쇄%손효강
神经胶质瘤%放射疗法,适形%体层摄影术,发射型计算机%体层摄影术,X线计算机%碳放射性同位素%甲硫氨酸
神經膠質瘤%放射療法,適形%體層攝影術,髮射型計算機%體層攝影術,X線計算機%碳放射性同位素%甲硫氨痠
신경효질류%방사요법,괄형%체층섭영술,발사형계산궤%체층섭영술,X선계산궤%탄방사성동위소%갑류안산
Glioma%Radiotherapy,conformal%Tomography,emission-computed%Tomography,X-ray computed%Carbon radioisotopes%Methionine
目的 对比MRI检查结果,探讨11C-MET PET/CT对高级别脑胶质瘤适形放疗方案制定的影响及价值.方法 回顾性研究2011年10月至2013年9月间经病理证实的25例初诊及9例复发的脑胶质瘤患者(男19例,女15例),所有患者均行11C-MET PET/CT及增强MRI检查,并分为初诊未手术组(17例)、初诊手术组(8例)、复发组(9例)3组,利用PET/CT图像勾画GTV并与MRIT1加权成像(T1WI)影像对比.结果 11C-MET PET/CT的应用优化了22例患者的放疗靶区,其中初诊未手术组7例,初诊手术组8例,复发组7例.初诊未手术组中,GTV与MRIT1WI异常强化体积(VMRI)一致者10例,GTV大于VMRI者5例,GTV小于VMRI者2例;初诊手术组中,GTV均小于VMRI;复发组中,GTV与VMRI一致者2例,GTV大于VMRI者2例,GTV小于VMRI者4例,1例GTV大部分位于VMRI之外.结论 11C-MET PET/CT对高级别胶质瘤病变范围的显示与MRI异常强化范围存在一定差异,结合11C-MET PET/CT勾画放疗靶区能明显优化高级别胶质瘤患者的放疗计划,对术后及复发病例应用价值可能更大.
目的 對比MRI檢查結果,探討11C-MET PET/CT對高級彆腦膠質瘤適形放療方案製定的影響及價值.方法 迴顧性研究2011年10月至2013年9月間經病理證實的25例初診及9例複髮的腦膠質瘤患者(男19例,女15例),所有患者均行11C-MET PET/CT及增彊MRI檢查,併分為初診未手術組(17例)、初診手術組(8例)、複髮組(9例)3組,利用PET/CT圖像勾畫GTV併與MRIT1加權成像(T1WI)影像對比.結果 11C-MET PET/CT的應用優化瞭22例患者的放療靶區,其中初診未手術組7例,初診手術組8例,複髮組7例.初診未手術組中,GTV與MRIT1WI異常彊化體積(VMRI)一緻者10例,GTV大于VMRI者5例,GTV小于VMRI者2例;初診手術組中,GTV均小于VMRI;複髮組中,GTV與VMRI一緻者2例,GTV大于VMRI者2例,GTV小于VMRI者4例,1例GTV大部分位于VMRI之外.結論 11C-MET PET/CT對高級彆膠質瘤病變範圍的顯示與MRI異常彊化範圍存在一定差異,結閤11C-MET PET/CT勾畫放療靶區能明顯優化高級彆膠質瘤患者的放療計劃,對術後及複髮病例應用價值可能更大.
목적 대비MRI검사결과,탐토11C-MET PET/CT대고급별뇌효질류괄형방료방안제정적영향급개치.방법 회고성연구2011년10월지2013년9월간경병리증실적25례초진급9례복발적뇌효질류환자(남19례,녀15례),소유환자균행11C-MET PET/CT급증강MRI검사,병분위초진미수술조(17례)、초진수술조(8례)、복발조(9례)3조,이용PET/CT도상구화GTV병여MRIT1가권성상(T1WI)영상대비.결과 11C-MET PET/CT적응용우화료22례환자적방료파구,기중초진미수술조7례,초진수술조8례,복발조7례.초진미수술조중,GTV여MRIT1WI이상강화체적(VMRI)일치자10례,GTV대우VMRI자5례,GTV소우VMRI자2례;초진수술조중,GTV균소우VMRI;복발조중,GTV여VMRI일치자2례,GTV대우VMRI자2례,GTV소우VMRI자4례,1례GTV대부분위우VMRI지외.결론 11C-MET PET/CT대고급별효질류병변범위적현시여MRI이상강화범위존재일정차이,결합11C-MET PET/CT구화방료파구능명현우화고급별효질류환자적방료계화,대술후급복발병례응용개치가능경대.
Objective To explore the impact and value of 11C-MET PET/CT for high-grade glioma in making conformal radiotherapeutic planning compared with MRI.Methods From October 2011 to September 2013,11C-MET PET/CT and MRI were performed in 25 initial glioma cases and 9 recurrent cases.All 34 cases (19 males,15 females) were classified into initial group (n=17),initial surgery group (n=8) and recurrent group (n=9).GTV was outlined using PET/CT images combined with T1 weighted MRI images.Results 11 C-MET PET/CT optimized radiotherapy targets in 22 cases,including 7 initial cases,8 initial surgery cases and 7 recurrent cases.GTV was consistent with the volume of abnormally enhanced region on T1 weighted MRI (VMRI) in 10 initial cases,GTV>VMRI in 5 cases,and GTV<VMRI in 2 cases.GTV<VMR1 in the initial surgery group.GTV was consistent with VMRI in 2 recurrent cases,GTV>VMRI in 2 cases and GTV<VMRI in 4 cases; 1 recurrent case's GTV located largely outside the VMRI.Conclusions There are some differences on locating the lesions of high-grade gliomas between 11C-MET PET/CT and MRI.Using 11CMET PET/CT in sketching radiotherapy target could significantly optimize the high grade glioma's radiotherapeutic planning,which may be more valuable in recurrent or operative cases.